Chugai Pharmaceutical Co. Ltd.

CHGCY | OTC

Price Alert Chart Builder DCF Calculator

$21.56

-$0.10 (-0.46%)

At close: Sep 23, 2026, 3:28 PM ET

$21.47

-$0.09 (-0.42%)

After-hours: Sep 23, 2026, 4:01 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 30, 2025	FY 2024 Dec 30, 2024	FY 2023 Dec 30, 2023	FY 2022 Dec 30, 2022	FY 2021 Dec 30, 2021	FY 2020 Dec 30, 2020
Revenue	1.26T	1.17T	1.11T	1.26T	999.76B	786.95B
Cost of Revenue	363.69B	339.86B	418.36B	476.88B	339.49B	275.17B
Gross Profit	894.25B	830.75B	693.01B	783.06B	660.27B	511.78B
Operating Income	590.19B	543.91B	415.67B	533.94B	433.74B	306.88B
Interest Income	3.6B	2.67B	1.78B	182M	166M	121M
Pretax Income	597.81B	543.03B	443.82B	531.17B	419.39B	298.19B
Net Income	434.01B	387.32B	325.47B	374.43B	303B	214.73B
Selling & General & Admin	116.46B	110.1B	112.58B	100.76B	95.25B	88.29B
Research & Development	187.6B	176.74B	164.76B	148.36B	131.28B	116.6B
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	304.06B	286.84B	277.34B	249.12B	226.53B	204.89B
Interest Expense	1.03B	95M	82M	60M	49M	60M
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	667.75B	626.7B	695.7B	726B	566.02B	480.06B
Income Tax Expense	163.79B	155.72B	118.35B	156.74B	116.39B	83.46B
Shares Outstanding (Basic)	1.65B	1.65B	1.65B	1.64B	1.64B	1.64B
Shares Outstanding (Diluted)	1.65B	1.65B	1.65B	1.65B	1.65B	1.65B
EPS (Basic)	263.73	235.39	197.83	227.64	184.29	130.66
EPS (Diluted)	263.72	235.36	197.80	227.57	184.17	130.53
EBITDA	631.37B	574.8B	475.64B	562.66B	450.3B	328.72B
EBIT	598.83B	543.13B	443.9B	531.23B	419.43B	298.25B
Depreciation & Amortization	32.54B	31.67B	31.74B	31.43B	30.87B	30.48B